Corcept Therapeutics CORT
NASDAQ CORT
$75.03 +2.26 (+3.11%)
At close: Nov 9, 2026 · 4:00 PM EST

Corcept Therapeutics (CORT) Return on Invested Capital [ROIC] (2017)

Updated

Corcept Therapeutics' Return on Invested Capital [ROIC] was 38.13% in Q4 2017, down 7.77 percentage points from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Return on Invested Capital [ROIC] (2017) Analysis & Trends

For FY2017, Return on Invested Capital [ROIC] at Corcept Therapeutics came in at 42.80%.

  • Quarterly Return on Invested Capital [ROIC] has moved between 24.51% (Q1 2017) and 45.90% (Q3 2017) over five years.
  • Per Business Quant data, CORT's Return on Invested Capital [ROIC] in the three quarters before Q4 2017 was 45.90% (Q3 2017), 39.00% (Q2 2017) and 24.51% (Q1 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.57%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 24.28%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.88%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 24.11%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 15.60%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.11%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 12.34%
10 Corcept Therapeutics 7.99 Bn 6.60 Bn 335.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 38.13%
Sep 30, 2017 45.90%
Jun 30, 2017 39.00%
Mar 31, 2017 24.51%
API Access

Corcept Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=CORT&period=max&api_key=YOUR_API_KEY